Healthcare providers relying on secure software in medical devices face challenges to secure software once the devices are in the field, with the FDA focusing on a rapid response to cybersecurity. Patching presents major difficulties, while defending against cyberattacks on devices requires appropriate cybersecurity measures, including self-defence solutions embedded in devices’ software. The incoming changes to FDA regulations necessitate more proactive, resilient security solutions.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
